Newcastle based company addresses key challenge to the success of lab-grown meat
With a predicted world population reaching just short of 10 billion by 2050 (3 billion more than there were in 2010), developing efficient, environmentally friendly and affordable food production technologies becomes a real challenge....
Nemera’s preservative-free multi-dose eyedropper approved in Brazil for Aché’s NSAID’s and Dry Eye formulations
Nemera is excited to announce that its multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug (NSAID) that is used...
Biofriendly protocells pump up blood vessels
An international team comprising researchers from the University of Bristol, and Hunan and Central South Universities in China, have prepared biocompatible protocells that generate nitric oxide gas – a known reagent for blood vessel...
New asthma treatment is a ‘game changer’
The first new asthma pill for nearly 20 years has the power to significantly reduce the severity of the condition, according to a study led by the University of Leicester.
The research funded by Novartis...
Ultra Scale-Down – Is this the answer to accelerated access of new medicines?
Afrin Zohura, USD Bioprocess Research Engineer, University College London (UCL)
How to develop new drugs, therapies and technologies in a timely manner is one of the most pressing concerns of our time. Recently, UK Business...
Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer’s
The findings demonstrate how the brain’s memory centre operates at a ‘watershed’ making it especially vulnerable to damage
Study suggests increasing blood flow in the hippocampus might be really effective at preventing...
Sumatra’s tigers defy expectations on genetic diversity
A joint study led by scientists from international conservation charity ZSL (Zoological Society of London) in collaboration with Imperial College London and Panthera, the global wild cat conservation organization, has revealed that despite low...
Qualification of the life cycle of reusable cleanroom garments
Qualification of the reusable cleanroom garment’s life cycle in a laundry, according to EU Annex 1
Reusable cleanroom garments are rightfully the most widely used solutions of protecting the final product and production from...
Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities
This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe.
Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in the...
The challenges inherent in Excipients
Have you ever wondered how a cough lozenge dissolves just at the right speed or how some medicines smell and taste so good? We have ‘excipients’ to thank for these useful properties in our...
Zotefoams’ ZOTEK® F foam chosen by InsulFab for safe and effective delivery of COVID-19...
High-performance closed cell, crosslinked fluoropolymer foam helps ensure safe and secure transportation of ultra-cold chain vaccine
As part of the USA’s Operation Warp Speed (OWS) initiative to combat the COVID-19 pandemic, Texas, USA-based InsulFab...
Eligible costs for R&D Tax Relief – it’s not just for those people in...
For my fellow professionals who work with businesses to support them with claims for Research and Development Tax Relief, one of our common mantras when explaining to manufacturing businesses, engineering firms and software developers...
Research deepens understanding of eczema
A research programme into genetics has identified new forms of the skin condition eczema and provided useful information that may lead to new treatments.
The work involves 16 researchers across four schools at the University...
Pioneering breakthrough in treatment of ‘devastating’ neurological disorder
IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease).
IB1001 demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning,...
RCSI researchers discover new way to halt excessive inflammation
RCSI researchers have discovered a new way to ‘put the brakes’ on excessive inflammation by regulating a type of white blood cell that is critical for our immune system.
The discovery has the potential to...
Why is Diligent Due Diligence Important?
Alex Bone, Patent Attorney, Partner, AA Thornton.
Background
Biopharma merger and acquisition activity was lower in 2021 than in recent years, but the top 10 deals still reached a combined value of over $50 billion. The main...